The Patent Litigation Committee and the ANDA & BPCIA Proceedings Subcommittee Present:
Section 112 Issues in ANDA and Biologics Litigation
Moderator:
Jenna Deneault, Counsel, Groombridge Wu
Panelists:
Jill Schmidt, Assistant General Counsel, Litigation, Genentech, Inc.
Laura Lydigsen, Partner, Crowell & Moring LLP
Hassen Sayeed, M.D., J.D., Partner, O’Melveny & Meyers LLP
Josephine Young, Partner, Groombridge Wu
Summary:
With the Supreme Court poised to take up Section 112 issues, the panel will review the current state of section 112 issues in ANDA and biologics litigation, and discuss where we will go from here.
Pricing:
Private Practitioner Cost:
FCBA Member - Complimentary
Non-Member $175
Government/Academic/Retired/Student Cost:
FCBA Member - Complimentary
Non-Member: $50
CLE Information:
FCBA is an approved provider with most states requiring CLE. Individual states have different approval guidelines and timeframes, and the FCBA cannot guarantee a state’s approval of CLE credit for any webcast or other program session.
For information on CLE accreditation, please contact our CLE Manager at cle@fedcirbar.org.